Morgan Stanley’s Marker Therapeutics MRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$613 Buy
401
+8
+2% +$12 ﹤0.01% 7408
2025
Q1
$483 Buy
393
+35
+10% +$43 ﹤0.01% 7376
2024
Q4
$1.11K Sell
358
-3,050
-89% -$9.48K ﹤0.01% 7259
2024
Q3
$9.61K Hold
3,408
﹤0.01% 6727
2024
Q2
$18.5K Sell
3,408
-632
-16% -$3.43K ﹤0.01% 6492
2024
Q1
$17.4K Sell
4,040
-3,156
-44% -$13.6K ﹤0.01% 6533
2023
Q4
$39.6K Buy
7,196
+5,256
+271% +$28.9K ﹤0.01% 6447
2023
Q3
$8.81K Hold
1,940
﹤0.01% 6776
2023
Q2
$6.01K Hold
1,940
﹤0.01% 6944
2023
Q1
$1.38K Buy
1,940
+31
+2% +$22 ﹤0.01% 7300
2022
Q4
$5.08K Buy
1,909
+1
+0.1% +$3 ﹤0.01% 7141
2022
Q3
$7K Sell
1,908
-1
-0.1% -$4 ﹤0.01% 7181
2022
Q2
$6K Sell
1,909
-375
-16% -$1.18K ﹤0.01% 7363
2022
Q1
$10K Sell
2,284
-1,096
-32% -$4.8K ﹤0.01% 7403
2021
Q4
$32K Sell
3,380
-254
-7% -$2.41K ﹤0.01% 7009
2021
Q3
$61K Sell
3,634
-1,489
-29% -$25K ﹤0.01% 6629
2021
Q2
$143K Buy
5,123
+3,587
+234% +$100K ﹤0.01% 6180
2021
Q1
$34K Sell
1,536
-1,499
-49% -$33.2K ﹤0.01% 6525
2020
Q4
$43K Buy
3,035
+2,652
+692% +$37.6K ﹤0.01% 6203
2020
Q3
$6K Sell
383
-715
-65% -$11.2K ﹤0.01% 6411
2020
Q2
$23K Buy
1,098
+452
+70% +$9.47K ﹤0.01% 5973
2020
Q1
$12K Sell
646
-18,086
-97% -$336K ﹤0.01% 5974
2019
Q4
$540K Buy
18,732
+3,794
+25% +$109K ﹤0.01% 4884
2019
Q3
$764K Buy
14,938
+14,505
+3,350% +$742K ﹤0.01% 4452
2019
Q2
$34K Sell
433
-685
-61% -$53.8K ﹤0.01% 5755
2019
Q1
$73K Buy
1,118
+594
+113% +$38.8K ﹤0.01% 5521
2018
Q4
$29K Buy
524
+187
+55% +$10.3K ﹤0.01% 5933
2018
Q3
$30K Sell
337
-66
-16% -$5.88K ﹤0.01% 6026
2018
Q2
$38K Buy
403
+377
+1,450% +$35.5K ﹤0.01% 5985
2018
Q1
$1K Buy
26
+25
+2,500% +$962 ﹤0.01% 6543
2017
Q4
$0 Hold
1
﹤0.01% 6616
2017
Q3
$0 Hold
1
﹤0.01% 6577
2017
Q2
$0 Hold
1
﹤0.01% 6623
2017
Q1
$0 Hold
1
﹤0.01% 6592
2016
Q4
$0 Buy
+1
New ﹤0.01% 6542